Table 1.

Variables in patients with or without treatment responses and relapses.

	Treatment response		Relapse
	Responder	Non-responder	Relapsed	Non-relapsed
	(n = 93)	(n = 21)	(n = 44)	(n = 106)
Male: female	67:26	15:6	33:11	68:38
Disease duration (years)	5.60 ± 3.46	4.81 ± 3.31	7.43 ± 4.53	5.81 ± 3.45
Maximal serum IgG4 concentration (mg/dL)	837.40 ± 557.94	831.05 ± 550.83	826.80 ± 556.77	862.81 ± 631.78
Number of affected organs	3.35 ± 2.19	3.10 ± 2.07	3.43 ± 1.85	3.30 ± 2.18
Reduction rate in the first 3 months	0.60 ± 0.18	0.64 ± 0.23	0.64 ± 0.18	0.59 ± 0.17
Reduction rate in the first 6 months	0.75 ± 0.15	0.72 ± 0.19	0.77 ± 0.16	0.74 ± 0.14
Reduction speed of initial dose of GC (mg/day)	0.34 ± 0.38	0.34 ± 0.33	0.46 ± 0.57	0.29 ± 0.19
Initial dose of GC (%)
<0.39 mg/kg/day	64.50	35.50	40.91	59.09
0.4–0.69 mg/kg/day	85.90	14.10	22.64	77.36
>0.7 mg/kg/day	75.00	25.00	54.17	45.83

GC: glucocorticoid.